Cargando…
Immunotherapy in Chronic Lymphocytic Leukaemia (CLL)
Chronic lymphocytic leukaemia (CLL) is well known to generate impaired immune responses in the host, with the malignant clone residing in well-vascularized tissues and circulating in peripheral blood but also in close proximity to effector cells that are capable, if activated appropriately, of elici...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer US
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4796351/ https://www.ncbi.nlm.nih.gov/pubmed/26857283 http://dx.doi.org/10.1007/s11899-015-0295-9 |